Switch to:
More From Other Websites
Did This Beauty Giant Just Solve The Acne Challenge? Mar 28 2017
2016’s Top Earning Hedge Fund Managers And Their Favorite Stocks Mar 28 2017
Allergan Acne Candidate Meets Endpoints in Phase III Studies Mar 28 2017
Blog Coverage Allergan and Paratek's Acne Drug Reported Positive Results Mar 28 2017
Risk-Reward With Teva Pharmaceutical Mar 27 2017
Health care showdown: Allergan vs. Valeant Mar 27 2017
Has Allergan's Pullback Ended? Mar 27 2017
Why Moat Indexes Outperformed Others in February Mar 27 2017
Allergan, Paratek’s Acne Drug Succeeds in Phase 3 Mar 27 2017
Paratek eyes FDA filing as acne drug clears late-stage trials Mar 27 2017
Foamix Acne Drug Fails Late-Stage Study Mar 27 2017
Skincare Makers Lead Biotech Movers Mar 27 2017
Allergan, Paratek Pharma report positive results in late-stage trial of acne treatment Mar 27 2017
Allergan and Paratek Announce Positive Results From Two Phase 3 Trials of Sarecycline for the... Mar 27 2017
Allergan and Paratek Announce Positive Results From Two Phase 3 Trials of Sarecycline for the... Mar 27 2017
Can Anyone Challenge Allergan In Medical-Aesthetics Market? Mar 24 2017
After Trump rally, equity investors move into healthcare, retailers Mar 24 2017
The Most Attractive Value Stock There Is? Mar 23 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK